Cell-growth control by monomeric antigen: the cell surface expression of lysozyme-specific Ig V-domains fused to truncated Epo receptor

Previously we have shown that the V H and V L fragments of an anti-hen egg lysozyme (HEL) antibody HyHEL-10 are weakly associated but can be driven together by antigen. By joining these antibody variable domains to the cytoplasmic portion of the murine erythropoietin receptor, we created a chimeric...

Full description

Saved in:
Bibliographic Details
Published in:Journal of immunological methods Vol. 241; no. 1; pp. 159 - 170
Main Authors: Ueda, Hiroshi, Kawahara, Masahiro, Aburatani, Takahide, Tsumoto, Kouhei, Todokoro, Kazuo, Suzuki, Eiji, Nishimura, Hajime, Schueler, Paula A, Winter, Greg, Mahoney, Walt C, Kumagai, Izumi, Nagamune, Teruyuki
Format: Journal Article
Language:English
Published: Amsterdam Elsevier B.V 31-07-2000
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previously we have shown that the V H and V L fragments of an anti-hen egg lysozyme (HEL) antibody HyHEL-10 are weakly associated but can be driven together by antigen. By joining these antibody variable domains to the cytoplasmic portion of the murine erythropoietin receptor, we created a chimeric growth factor receptor that could be activated by HEL. After co-transfection with two plasmids encoding the respective chimeric receptors in IL-3 dependent murine pro-B Ba/F3 cells, a portion of the cells survived under antigen dependent stimulation without IL-3. These surviving cells all showed coexpression of the two chimeric receptor chains and demonstrated HEL dose-dependent growth stimulation without IL-3. When another IL-3 dependent cell line 32D was transfected with a variant of such chimeric receptor with a linker peptide (Gly–Ser–Gly) inserted between V H/V L and EpoR domains, an improved growth response was attained. These observations suggest the utility of heterodimeric Fv chimeric receptors in creating cells that respond to monomeric antigen.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1759
1872-7905
DOI:10.1016/S0022-1759(00)00202-7